Amarantus BioSciences, Inc. Posts LymPro Test® Alzheimer's Diagnostic White Paper to Web Site
4/25/2013 1:26:07 PM
SUNNYVALE, Calif.--(BUSINESS WIRE)--Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, has posted to its Web site a White Paper discussing the investment opportunity in the Company’s LymPro Test® for Alzheimer’s disease from a scientific perspective. The White Paper can be found at http://ir.stockpr.com/amarantus/scientific-publications.
comments powered by